MEMORY PHARMACEUTICALS CORP (MEMY) [Rocket]

In millions, except per share items	Dec-31-07	Dec-31-06	Dec-31-05	Dec-31-04	Dec-31-03	Dec-31-02
	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	11.5	9.3	11.1	9.8	7.6	1.2
Revenue growth	23.6%	-16.1%	13.6%	28.4%	544.0%
Cost of goods sold	9.3	8.4	8.4	7.4	7.1	4.5
Gross profit	2.2	0.9	2.7	2.4	0.5	-3.3
Gross margin	19.1%	9.4%	24.0%	24.4%	6.7%	-279.5%
Selling, general and administrative [+]	9.3	8.4	8.4	7.4	7.1	4.5
General and administrative	9.3	8.4	8.4	7.4	7.1	4.5
Other operating expenses	29.0	25.4	25.2	19.6	15.5	17.5
EBITDA [+]	-34.2	-30.8	-28.8	-22.5	-20.3	-23.8
EBITDA growth	10.9%	7.0%	27.9%	10.9%	-14.6%
EBITDA margin	-296.8%	-330.8%	-259.5%	-230.4%	-266.7%	-2010.7%
Depreciation and amortization	2.0	2.1	2.2	2.1	1.8	1.5
EBIT [+]	-36.2	-32.9	-31.0	-24.6	-22.1	-25.3
EBIT growth	9.8%	6.1%	26.1%	11.2%	-12.4%
EBIT margin	-313.9%	-353.2%	-279.1%	-251.4%	-290.4%	-2135.0%
Interest income, net [+]	0.8	1.7	0.8	0.2	0.0	0.1
Interest expense	1.6	0.2	0.3	0.4	0.5	0.4
Interest income	2.4	1.9	1.0	0.7	0.5	0.5
Other income (expense), net	0.1	-0.2	-1.6		0.1
Pre-tax income	-35.3	-31.5	-31.9	-24.3	-22.0	-25.1
Income taxes	0.0	-0.4	-0.2	-0.2	-0.2	0.0
Tax rate		1.2%	0.7%	1.0%	0.8%
Net income	-35.3	-31.1	0.0	0.0	0.0	0.0
Net margin	-306.3%	-333.7%	-0.3%	-0.3%	-0.4%	-2.6%

Basic EPS [+]	($0.49)	($0.70)	($1.20)	($1.67)	($30.07)	($48.10)
Growth	-30.0%	-41.7%	-28.1%	-94.4%	-37.5%
Diluted EPS [+]	($0.49)	($0.70)	($1.20)	($1.67)	($30.07)	($48.10)
Growth	-30.0%	-41.7%	-28.1%	-94.4%	-37.5%

Shares outstanding (basic) [+]	71.9	44.3	0.0	0.0	0.0	0.0
Growth	62.1%	168149.7%	68.8%	1502.9%	50.8%
Shares outstanding (diluted) [+]	71.9	44.3	0.0	0.0	0.0	0.0
Growth	62.1%	168149.7%	68.8%	1502.9%	50.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.